5-(2-bromovinyl)-2'-deoxyuridylate: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 6505368 |
CHEMBL ID | 1231519 |
SCHEMBL ID | 5009511 |
SCHEMBL ID | 4265437 |
MeSH ID | M0118841 |
Synonym |
---|
5'-uridylic acid, 5-(2-bromoethenyl)-2'-deoxy- |
83378-41-0 |
5-(2-bromovinyl)-2'-deoxyuridylate |
CHEMBL1231519 |
bvdu 5'-monophosphate |
brivudine monophosphate |
DB04438 |
bvdu-mp |
brvdump |
o7n0y11u8k , |
5'-uridylic acid, 5-((1e)-2-bromoethenyl)-2'-deoxy- |
unii-o7n0y11u8k |
80860-82-8 |
SCHEMBL5009511 |
SCHEMBL4265437 |
(e)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate |
5-[(e)-2-bromoethenyl]-2'-deoxyuridine 5'-(dihydrogen phosphate) |
Q27285444 |
((2r,3s,5r)-5-(5-((e)-2-bromovinyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID74257 | The compound was tested for inhibition of the rate of 1 uM UDP-[3H]-GlcNAc import into the lumen of the Golgi membranes. | 1996 | Journal of medicinal chemistry, Jul-19, Volume: 39, Issue:15 | Inhibition of UDP-N-acetylglucosamine import into Golgi membranes by nucleoside monophosphates. |
AID87826 | Evaluation of antiviral activity against Herpes simplex virus type 2 (HSV-2) strain 196. | 1986 | Journal of medicinal chemistry, Jul, Volume: 29, Issue:7 | Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. |
AID87827 | Evaluation of antiviral activity against Herpes simplex virus type 2 (HSV-2) strain G | 1986 | Journal of medicinal chemistry, Jul, Volume: 29, Issue:7 | Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. |
AID87508 | Evaluation of antiviral activity against Herpes simplex virus type 1 (HSV-1) strain McIntyre | 1986 | Journal of medicinal chemistry, Jul, Volume: 29, Issue:7 | Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. |
AID216539 | Evaluation of antiviral activity against Vesicular stomatitis virus. | 1986 | Journal of medicinal chemistry, Jul, Volume: 29, Issue:7 | Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. |
AID74254 | Inhibitory concentration at which there is accumulation of UDP-[3H]-GlcNAc in the lumen of the Golgi membranes; Not determined | 1996 | Journal of medicinal chemistry, Jul-19, Volume: 39, Issue:15 | Inhibition of UDP-N-acetylglucosamine import into Golgi membranes by nucleoside monophosphates. |
AID87828 | Evaluation of antiviral activity against Herpes simplex virus type 2 (HSV-2) strain Lyons | 1986 | Journal of medicinal chemistry, Jul, Volume: 29, Issue:7 | Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. |
AID87507 | Evaluation of antiviral activity against Herpes simplex virus type 1 (HSV-1) strain KOS. | 1986 | Journal of medicinal chemistry, Jul, Volume: 29, Issue:7 | Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. |
AID87506 | Evaluation of antiviral activity against Herpes simplex virus type 1 (HSV-1) strain F | 1986 | Journal of medicinal chemistry, Jul, Volume: 29, Issue:7 | Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. |
AID218132 | Evaluation of antiviral activity against Vaccinia virus | 1986 | Journal of medicinal chemistry, Jul, Volume: 29, Issue:7 | Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.42) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |